P PRIMESTOCKFINDER.COM

OCA Shares Oceania Healthcare Limited

ASX · ASX
$0.54 +0.00% Prices as of close 2026-10-27

Last in our picks 2026-10-01 — not in the current list; analysis below is from that screen

Not currently listed on ASX in this form.

Future value: $1.00 (+68.07%) · 6-12 months

  • ▸Invalid current ASX energy listing.
  • ▾Below 50-day MA (-5.39%)
  • ▸~68% upside to price target

Trend: OCA is trading below the 50-day average (-8.47%), RSI 42 — neutral momentum, with a 3-month return of -13.60%.

Valuation & quality: Oceania Healthcare Limited trades on price-to-book 0.41; fundamentals show net margin 0.0%, return on equity 0.0%, revenue growth 7.6% year on year.

Our screen: ACCUMULATE (score 1) — Not currently listed on ASX in this form.

Computed from end-of-day data; not personal advice.

0.69 0.52 FebMarAprMayJunJulAugSepOct
Daily close, 2026-02-08 → 2026-10-25 (AUD). Range 0.52 – 0.69.
Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
-7.20%-6.20%+6.70%-4.70%+1.60%+4.80%-7.70%-10.00%
Market cap
$393.0M
EPS (ttm)
$0.00
Price / book
0.41
Beta
0.60
Net margin
0.0%
ROE
0.0%
Revenue growth
7.6%
Revenue (ttm)
$268.8M
Free cash flow
$129.6M
Debt / equity
45%
52-wk range
$0.52 – $0.82
Volume
6
Avg volume (3m)
15,612
RSI (14)
41.9
vs 50-day MA
-8.47%
1-mo return
-9.24%
3-mo return
-13.60%
Volume z-score
-0.41

Oceania Healthcare Limited, together with its subsidiaries, owns and operates retirement villages and care centres in New Zealand. The company operates through Care Operations, Village Operations, and Others segments.

Sector: Healthcare · Industry: Medical Care Facilities · New Zealand · 2,246 employees · Website

Browse: all ASX stocks · Energy picks · today's movers

General information only (Australia). This is general information, not financial product advice. It doesn't consider your objectives, financial situation or needs — consider its appropriateness and seek licensed advice before acting. Not a recommendation to buy or sell any financial product.

Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.